Stock To Watch: This Hospital Stock Rises 42% In 1 Month, Healthy Earning Growth

The share price of Lotus Eye Hospital and Institute Ltd. has surged consistently on a long-term and short-term basis. Significantly this year, this small-cap stock is performing even better, compared to the last year. Check details here.

Stock to Watch: NSE performance

The current market price of Lotus Eye Hospital and Institute Ltd. stood at Rs. 78/share on NSE, gaining by 12.64%, till last traded. In the last 5 days, the share price of this company has surged by 23.61% on NSE, and in the last 1 month, its share price has surged by 41.82%. In the past 6 months, its stock price has surged by 14.29%. In the last 1 year its stock price gained by 64.38%. Watching the consistently high returns, investors can look out for this stock.

The 52-week high level of this stock is Rs. 80.00, and the 52-week low level of this stock is Rs. 38.25.

Market capitalization	Current market price	5 days performance	6 Months performance
Rs. 162 crore	Rs. 78	23.61%	14.29%

Financial performance

According to data available with NSE, in Q4 FY22, the company's total income stood at Rs. 1,085.68 lakh, as against Rs. 1,182.33 lakh in the previous quarter. The company's profit before tax or PBT was reported at Rs. 74.51 lakh in Q4 FY22, as against Rs. 189.52 lakh in Q3 FY22. The company's net profit was reported at Rs. 54.11 lakh in Q4 FY22, as against Rs. 138.57 lakh in Q3 FY22.

Commenting about the stock, simplywall.st noted, "It is quite clear that Lotus Eye Hospital and Institute's ROE is rather low. Not just that, even compared to the industry average of 16%, the company's ROE is entirely unremarkable. Despite this, surprisingly, Lotus Eye Hospital and Institute saw an exceptional 22% net income growth over the past five years. We believe that there might be other aspects that are positively influencing the company's earnings growth. For instance, the company has a low payout ratio or is being managed efficiently. In total, it does look like Lotus Eye Hospital and Institute has some positive aspects to its business. With a high rate of reinvestment, albeit at a low ROE, the company has managed to see a considerable growth in its earnings."

Disclaimer

Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, and the author are not liable for any losses caused as a result of decisions based on the article.